Advanced Cancer

FDA Approves Ibrance (Palbociclib) for Breast Cancer

The US Food and Drug Administration (FDA) has approved a new drug for women with a certain type of breast cancer that has metastasized – spread to other parts of the body.

Studies Examine Doctor-Patient Communication about End-of-life Care

Two studies led by researchers from Dana-Farber Cancer Institute conclude a frank discussion with their doctor can help terminally ill cancer patients achieve better quality of life before they die.